Pancreatic Cyst Treatment

in Hyderabad, India

PACE Hospitals is regarded as one of the best hospitals for pancreatic cyst treatment in Hyderabad, Telangana, India. Our expert team of gastroenterologists, endocrinologists, surgeons, and dietitians offers a multidisciplinary approach to diagnosing and managing various types of pancreatic cysts, including pseudocysts, mucinous cystic neoplasms (MCNs), and intraductal papillary mucinous neoplasms (IPMNs). We use advanced imaging techniques such as MRI, CT, and endoscopic ultrasound (EUS) to assess cyst characteristics and determine the most appropriate course of action based on risk factors and symptoms.

We offer tailored treatment plans that may include medications, enzyme therapy, drainage procedures, or surgery—focused on symptom relief, preventing complications, and improving quality of life.

Book an appointment for 

Pancreatic Cyst Treatment

Why Choose PACE Hospitals for Pancreatic Cyst Treatment?

Diagnostic Tests

Based on the above evaluation, doctors select the most appropriate diagnostic tests to confirm the presence of a pseudocyst and guide treatment:

Blood tests

• Complete blood count (CBC)
• Liver function tests (LFTs) 
• Kidney function test

Imaging studies

• CT scan
• MRCP 
• MRI 
• Trans Abdominal Ultrasound
• Endoscopic ultrasonography (EUS) 
• Endoscopic retrograde cholangiopancreatography (ERCP)

Biopsies

• EUS-guided FNA

Cytology, smears

• Cyst fluid analysis

Blood tests

• Complete blood count: A CBC can detect signs of infection or inflammation, such as elevated white blood cell counts, which may suggest an infected cyst or pancreatitis. Anaemia might indicate chronic disease or bleeding within the cyst. 
• Liver Function Tests (LFTs): Elevated liver enzymes and bilirubin levels can indicate biliary obstruction due to cyst compression, necessitating prompt intervention to prevent liver damage.
• Kidney Function Tests: Assessing renal function is essential, especially before administering contrast agents for imaging studies. Impaired kidney function may limit diagnostic and therapeutic options.

Imaging Studies 

• Computed Tomography (CT): CT scans provide detailed cross-sectional images, aiding in assessing cyst size, location, and potential involvement of adjacent structures. They are instrumental in detecting calcifications or septations within the cyst.
• Magnetic Resonance Cholangiopancreatography (MRCP): MRCP offers non-invasive visualization of the pancreatic and biliary ducts, helping to identify communication between the cyst and ductal systems, which is crucial for classification and management.
• Magnetic Resonance Imaging (MRI): MRI provides high-contrast images, allowing for better characterization of cyst contents and wall features. It is particularly useful in differentiating mucinous from non-mucinous cysts.
• Transabdominal Ultrasound: This initial imaging modality can detect cysts and assess their size and location. However, its sensitivity is limited by patient body habitus and overlying bowel gas. 
• Endoscopic Ultrasonography (EUS): EUS offers high-resolution images and enables fine-needle aspiration (FNA) for cyst fluid analysis. It is invaluable in evaluating cyst wall characteristics and vascular involvement.
• Endoscopic Retrograde Cholangiopancreatography (ERCP): ERCP allows direct visualization and intervention within the pancreatic and biliary ducts. It is primarily used when therapeutic procedures, such as stenting are indicated.

Biopsies 

• EUS-Guided Fine-Needle Aspiration (FNA): EUS-guided FNA enables the collection of cyst fluid for cytological and biochemical analysis. This procedure aids in distinguishing benign from malignant cysts and guides management decisions.

Cytology and Smears 

• Cyst Fluid Analysis: Analysing cyst fluid for carcinoembryonic antigen (CEA) levels helps differentiate mucinous from non-mucinous cysts, with elevated CEA suggesting a mucinous origin. Amylase levels can indicate communication with the pancreatic duct, as seen in pseudocysts. Viscosity, glucose levels, and molecular markers further refine the diagnostic process.

Treatment Considerations

Before selecting the appropriate treatment for a pancreatic pseudocyst, healthcare professionals carefully evaluate several clinical factors to determine the most effective and safe approach for each patient. Key considerations include:

• History: Healthcare professional considers the patient complete history including medical, medication, social, family history and also physical evaluation.
• Risk stratification: It is vital for determining the need for surgery or close surveillance. Criteria include:
• High-risk stigmata: enhancing solid components, main pancreatic duct ≥10 mm, obstructive jaundice.
• Worrisome features: cyst ≥3 cm, thickened/enhancing walls, MPD size 5–9 mm, abrupt duct cut-off, lymphadenopathy.
• Cysts with high-risk stigmata often warrant surgical resection, while those with worrisome features may need further evaluation via EUS-FNA.
• Role of Tumor Markers in Cyst Fluid

Tumor markers and biochemical tests from cyst fluid obtained via EUS-FNA are essential in differentiating pseudocysts from other cystic pancreatic lesions.

• Several biomarkers enhance diagnostic accuracy:
• Carcinoembryonic Antigen (CEA): High levels (>192 ng/mL) suggest mucinous cysts.
• Amylase: Elevated in pseudocysts due to pancreatic enzyme content; low in mucinous cysts
• Glucose: Low glucose (<50 mg/dL) in mucinous cysts.
• DNA Analysis: KRAS and GNAS mutations support a diagnosis of mucinous cysts/IPMNs.
• Molecular markers may soon guide targeted therapies as research progresses.

Book online appointment​

Treatment strategies depend on the cyst's type, size, symptomatology, and malignant potential. Options range from conservative management to surgical intervention, including:

• Conservative treatments 
• Medications 
• Antibiotics 
• Enzyme replacement therapy 
• Monitoring & Observation 
• Regular Imaging 
• Observation 
• Drainage Procedures 
• Endoscopic Drainage 
• Percutaneous Drainage
• Surgical Treatments 
• Cyst Resection 
• Pancreaticoduodenectomy (Whipple Procedure) 
• Other Procedures 
• Sclerotherapy 
• Ethanol Injection

Conservative treatments

Conservative management of pancreatic cysts is aimed at relieving symptoms, promoting spontaneous resolution, and preventing complications in stable patients. Here are some of the non-surgical treatment approaches that may be considered for the conservative management of a pancreatic cyst:

Medications

Symptomatic relief can be achieved with analgesics and pancreatic enzyme supplements, especially in cases of exocrine insufficiency. These measures do not alter the cyst's course but improve the quality of life.

• Antibiotics: Infected cysts or those at risk of infection may require antibiotic therapy. Empirical treatment is initiated based on clinical suspicion and adjusted according to culture results.
• Enzyme Replacement Therapy: For patients with pancreatic exocrine insufficiency, enzyme supplementation aids digestion and nutrient absorption, mitigating symptoms like steatorrhea and weight loss.

Monitoring & Observation 

Asymptomatic cysts without high-risk features can be monitored with periodic imaging to detect changes in size or characteristics that might necessitate intervention. This approach minimizes unnecessary procedures.

• Regular Imaging: Scheduled imaging studies, such as MRI or EUS, track cyst evolution over time, ensuring timely detection of concerning changes. The frequency of surveillance depends on initial cyst features.
• Observation: A watchful waiting approach is suitable for low-risk cysts, especially in elderly or comorbid patients for whom surgical risks outweigh potential benefits. Regular follow-up ensures prompt action if the cyst evolves.

Drainage Procedures 

These are recommended when a pancreatic cyst becomes symptomatic, infected, or causes complications such as obstruction or pain. These procedures help relieve symptoms, reduce the risk of rupture or infection, and are often used when the cyst is not suitable for immediate surgical removal: 

• Endoscopic Drainage: Endoscopic techniques allow internal drainage of pseudocysts into the gastrointestinal tract, providing symptom relief and resolving the cyst without external incisions. This minimally invasive approach reduces recovery time.
• Percutaneous Drainage: Under imaging guidance, a catheter is inserted through the skin to drain the cyst externally. This method is typically reserved for infected or symptomatic pseudocysts not amenable to endoscopic drainage.

Surgical Treatments

These are recommended for pancreatic cysts that show high-risk features for malignancy, are increasing in size, or are symptomatic and cannot be managed with drainage alone. Surgery allows for the complete removal of the cyst, reducing the risk of cancer development and recurrence.

• Cyst Resection: Surgical removal of the cyst is indicated for symptomatic, large, or potentially malignant lesions. The extent of resection depends on the cyst's location and involvement of surrounding structures.
• Pancreaticoduodenectomy (Whipple Procedure): This extensive surgery involves removing the pancreatic head, duodenum, gallbladder, and part of the bile duct. It is reserved for cysts with high malignant potential or confirmed cancer in the pancreatic head.

Other Procedures

Other procedures like sclerotherapy and ethanol injection are considered for pancreatic cysts that are not suitable for surgery, especially in patients with high surgical risk or small, well-defined cysts. These minimally invasive options aim to reduce cyst size or eliminate it while avoiding major surgery.

• Sclerotherapy: Sclerotherapy involves injecting a sclerosing agent into the cyst to induce fibrosis and obliteration. It is considered for select cysts, particularly when surgery is contraindicated.
• Ethanol Injection: Ethanol ablation entails injecting alcohol into the cyst cavity to destroy the epithelial lining, leading to cyst resolution. This minimally invasive technique is an option for certain mucinous cysts.

Follow-up Guidelines

Based on Cyst Type and Size, Surveillance recommendations vary by international guidelines (e.g., AGA, Fukuoka):

• <1.5 cm cysts without worrisome features: Imaging every 2–3 years
• 1.5–2.5 cm cysts: Annual imaging
• 3 cm or with features: Shorter intervals, consider EUS
• No further follow-up after 5–10 years of stability in low-risk cysts, depending on age and comorbidities

Pancreatic Cyst Surgery Cost in Hyderabad, India

The cost of pancreatic cyst surgery in Hyderabad, India varies based on the surgical procedure, hospital facilities, surgeon’s expertise, and individual medical factors. On average:

• Whipple’s Procedure (Pancreaticoduodenectomy): ₹2,50,000 to ₹6,50,000 (US$3,000 – US$7,800)
• Other Procedures (Distal Pancreatectomy, Total Pancreatectomy, Frey’s Procedure): ₹2,75,000 to ₹8,50,000 (US$3,300 – US$10,200)

Key Factors Affecting Pancreatic Surgery Cost

• Type of Surgery: Whipple’s Procedure, Distal Pancreatectomy, Total Pancreatectomy, and Frey’s Procedure each have different cost implications based on complexity.
• Hospital Infrastructure: Multi-specialty and private hospitals in Hyderabad may charge higher due to advanced facilities and ICU setup.
• Surgeon’s Expertise: Highly experienced pancreatic surgeons or HPB specialists may have higher consultation and surgery fees.
• Length of Stay & Complications: Typical hospital stay is 9–12 days. Extended ICU stays or post-op complications increase costs.
• Pre-operative & Post-operative Care: Includes CT/MRI scans, blood tests, biopsy, medications, follow-up consultations and in some cases, rehabilitation.
• Additional Charges: Includes anesthesia, operation theatre use, consumables, bed charges, and post-op monitoring.

Frequently Asked Questions (FAQs) on Pancreatic Cysts

Which types of pancreatic cysts are most likely to become cancerous?

Mucinous cystic neoplasms (MCNs) and intraductal papillary mucinous neoplasms (IPMNs) have the highest potential for malignancy among pancreatic cysts.

What causes pancreatic cysts to form?

Pancreatic cysts can form due to pancreatitis, trauma, genetic mutations, or as a result of abnormal ductal growths in the pancreas.

Are there risk factors for developing pancreatic cysts?

Yes, risk factors include chronic pancreatitis, family history of pancreatic diseases, smoking, heavy alcohol use, and certain genetic syndromes.

What is a precancerous pancreatic cyst?

A precancerous pancreatic cyst is a fluid-filled sac in the pancreas that has the potential to develop into pancreatic cancer over time. Common types include intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms (MCNs), which require careful monitoring or surgical removal based on size, symptoms, and risk of malignancy.

What symptoms might indicate the presence of a pancreatic cyst?

Symptoms may include abdominal pain, bloating, nausea, jaundice, or unintended weight loss, depending on the cyst’s size and location.

Can pancreatic cysts be asymptomatic?

Yes, many pancreatic cysts are asymptomatic and are discovered incidentally during imaging for unrelated health issues.

When is surgery recommended for a pancreatic cyst?

Surgery is considered when the cyst shows suspicious features, causes symptoms, grows over time, or has malignant potential.

What size is considered a large pancreatic cyst?

A pancreatic cyst is generally considered large if it measures 3 cm (30 mm) or more in diameter. Larger cysts, especially those over 3 cm, may carry a higher risk of malignancy and often require closer monitoring or further evaluation.

What is the long-term outlook for someone with a pancreatic cyst?

The outlook depends on the type and behaviour of the cyst; benign cysts often require monitoring, while precancerous or cancerous ones need intervention.